Blastogenic suppression and alloantibody activity of sera from renal allograft recipients

A. H. Johnson, R. D. Rossen, E. M. Hersh, S. S. Farrow, W. T. Butler, W. N. Suki

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


To evaluate whether immunological enhancement plays a role in adaptation to renal allografts, the authors studied sera from transplant recipients to determine whether those which suppressed mixed leukocyte culture (MLC) responses in vitro contained alloantibodies reactive with donor cells. Sera from 5 of 9 renal transplant recipients consistently and specifically suppressed autologous MLC responses to donor cells without impairing the blastogenic responses to third party leukocytes, soluble antigens, or nonspecific mitogenic agents. In 3 of the 5 cases the suppressive activity of the serum was striking; in 2 cases the effect was less marked but still readily demonstrable in studies designed to evaluate the dose of serum which provided optimal suppression of MLC responses. Serum from one of the recipients nonspecifically suppressed blastogenic activity both to donor cells and other stimuli. No alloantibody reactive with donor leukocytes was found in any of the sera which exhibited suppressive activity in MLC, whereas in one patient, serum which contained antibody reactive with donor cells did not suppress MLC response to that donor. These findings suggest that, if the serum factors which suppress MLC responses in vitro are enhancing antibodies, they are not detectable even with very sensitive techniques either because they are present in very low concentrations, belong to immunoglobulin classes other than IgA, IgG, or IgM, or are complexed with donor antigen in such a way that their ability to react with fresh donor cells in vitro is blocked.

Original languageEnglish (US)
Pages (from-to)270-278
Number of pages9
JournalUnknown Journal
Issue number1
StatePublished - 1974

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Blastogenic suppression and alloantibody activity of sera from renal allograft recipients'. Together they form a unique fingerprint.

Cite this